Siemens Healthineers is expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test to detect the presence of SARS-CoV-2 antibodies in blood. The test will be available on the Atellica® Solution immunoassay analyzer, which can run up to 440 tests per hour and will enable a result in just 14 minutes. Siemens Healthineers anticipates availability of the total antibody test by late May 2020. Planned expanded production in the company’s Walpole, Massachusetts manufacturing facility will accommodate more than 25 million tests per month in June and beyond.
An affiliate of the U.S. Chamber of Commerce